Literature DB >> 20005903

Rapid method for SV40 titration.

Nir Drayman1, Slava Kler, Orly Ben-nun-Shaul, Ariella Oppenheim.   

Abstract

SV40 titer is determined traditionally by the conventional plaque assay. Plaques appear after several rounds of infection and the assay takes around two weeks, which may delay research. A simpler assay was developed, based on detection of T-antigen in the infected cells by flow cytometry. Cells grown in 6-well plates are infected with serial dilutions of the viral stock, harvested 48h post-infection, stained and analyzed for T-antigen using a flow cytometer. The viral titer is calculated based on the percentage of T-antigen positive cells. The procedure is accomplished in 2 days. Unexpectedly we found that titers on different permissive African Green Monkey kidney cell lines were consistently different, suggesting variable susceptibility to SV40 infection. The method described, optimized for SV40 titration, may be adapted readily to other viruses. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20005903     DOI: 10.1016/j.jviromet.2009.12.003

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  10 in total

1.  Divergent MicroRNA targetomes of closely related circulating strains of a polyomavirus.

Authors:  Chun Jung Chen; Jennifer E Cox; Rodney P Kincaid; Angel Martinez; Christopher S Sullivan
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

2.  The viroporin activity of the minor structural proteins VP2 and VP3 is required for SV40 propagation.

Authors:  Kristina M Giorda; Smita Raghava; Macy W Zhang; Daniel N Hebert
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

3.  Simian virus 40 induces lamin A/C fluctuations and nuclear envelope deformation during cell entry.

Authors:  Veronika Butin-Israeli; Orly Ben-nun-Shaul; Idit Kopatz; Stephen A Adam; Takeshi Shimi; Robert D Goldman; Ariella Oppenheim
Journal:  Nucleus       Date:  2011-07-01       Impact factor: 4.197

4.  Naturally arising strains of polyomaviruses with severely attenuated microRNA expression.

Authors:  Chun Jung Chen; James M Burke; Rodney P Kincaid; Kristopher D Azarm; Noel Mireles; Janet S Butel; Christopher S Sullivan
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

5.  Rapid titration of measles and other viruses: optimization with determination of replication cycle length.

Authors:  Boyan Grigorov; Jessica Rabilloud; Philip Lawrence; Denis Gerlier
Journal:  PLoS One       Date:  2011-09-07       Impact factor: 3.240

6.  Linear correlation between average fluorescence intensity of green fluorescent protein and the multiplicity of infection of recombinant adenovirus.

Authors:  Yi-Chen Tsai; Tsung-Huang Tsai; Chen-Ping Chang; Shu-Fen Chen; Yen-Ming Lee; Song-Kun Shyue
Journal:  J Biomed Sci       Date:  2015-05-14       Impact factor: 8.410

7.  Collective interactions augment influenza A virus replication in a host-dependent manner.

Authors:  Ketaki Ganti; Nathan T Jacobs; Chung-Young Lee; Kara L Phipps; Silvia Carnaccini; Maria C White; Miglena Manandhar; Brett E Pickett; Gene S Tan; Lucas M Ferreri; Daniel R Perez; Anice C Lowen
Journal:  Nat Microbiol       Date:  2020-07-06       Impact factor: 17.745

Review 8.  Virus strategies for passing the nuclear envelope barrier.

Authors:  Oren Kobiler; Nir Drayman; Veronika Butin-Israeli; Ariella Oppenheim
Journal:  Nucleus       Date:  2012-08-28       Impact factor: 4.197

9.  Downregulation of the stress-induced ligand ULBP1 following SV40 infection confers viral evasion from NK cell cytotoxicity.

Authors:  Yoav Bauman; Nir Drayman; Orly Ben-Nun-Shaul; Alon Vitenstein; Rachel Yamin; Yael Ophir; Ariella Oppenheim; Ofer Mandelboim
Journal:  Oncotarget       Date:  2016-03-29

10.  p53 elevation in human cells halt SV40 infection by inhibiting T-ag expression.

Authors:  Nir Drayman; Orly Ben-Nun-Shaul; Veronika Butin-Israeli; Rohit Srivastava; Ariel M Rubinstein; Caroline S Mock; Ela Elyada; Yinon Ben-Neriah; Galit Lahav; Ariella Oppenheim
Journal:  Oncotarget       Date:  2016-08-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.